Researchers have discovered a potential neuroimaging biomarker that could help personalize treatments for depression.
McGill researchers have identified a small region in the genome that conclusively plays a role in the development of psychiatric disease and obesity.
The same gene variations that make it difficult to stop smoking also increase the likelihood that heavy smokers will respond to nicotine-replacement therapy and drugs that thwart cravings, a new study shows.
These findings are not about the classic story of gift-giving, although the MAGI genes (officially named membrane associated guanylate kinase, WW and PDZ domain containing proteins) do influence brain function in important ways.
A new report from Yale researchers considers the different biological mechanisms associated with cocaine addiction between men and women. It is hoped that the study could shed some light onto effective therapies to help curb cravings, and ultimately break the addiction cycle based upon the sex of the patient. The findings so far suggest that women could benefit from stress reduction therapies, while men might benefit more from cognitive behavioral therapies or more traditional 12 step programs.
A new report from psychiatrists at UT Southwestern has pointed to a correlation between low levels of vitamin D and depression. Researchers discovered that lower levels of vitamin D were apparent in people with current depressive symptoms, particularly those who had a history of depression. However, the researchers are yet to determine whether the low vitamin D levels contribute to depressive symptoms, or whether the depression contributes to lower levels of the vitamin.
New research from UC Davis has shown that psychiatrists are able to accurately assess patients mental health problems by viewing pre-recorded video interviews.